ArticleMolecular therapy oncolytics2021

Characterization of a novel OX40 ligand and CD40 ligand-expressing oncolytic adenovirus used in the PeptiCRAd cancer vaccine platform.

Erkko Ylösmäki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.